Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Pharoah

Showing results (41-50 of 566) with videos related to

Pageof 57
Sort By:
British Journal of Cancer|February 18, 2011
Patient and tumour characteristics, management, and age-specific survival in women with breast cancer in the East of EnglandA M G Ali, D Greenberg, G C Wishart, et al.
JAMA Oncology|July 7, 2018
Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table ModelNora Pashayan, Steve Morris, Fiona J Gilbert, et al.
Human Molecular Genetics|September 26, 2007
Cancer genetics of epigenetic genesAhmad Miremadi, Mikkel Z Oestergaard, Paul D P Pharoah, et al.
Plos Genetics|June 30, 2018
The importance of using public data to validate reported associationsGeorgia Chenevix-Trench, Jonathan Beesley, Paul D P Pharoah, et al.
Nature Reviews. Cancer|July 21, 2023
Polygenic scores in cancerXin Yang, Siddhartha Kar, Antonis C Antoniou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
An analysis of ovarian tumor diameter and survivalJ. F. Stratton, P. Pharoah, J. A. Tidy, et al.
Journal of Medical Ethics|April 4, 2003
Issues of consent and feedback in a genetic epidemiological study of women with breast cancerM P M Richards, M Ponder, P Pharoah, et al.
JAMA Network Open|March 11, 2021
Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate CancerThomas Callender, Mark Emberton, Stephen Morris, et al.
BMC Cancer|May 31, 2008
Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancerGrace M Callagy, Mark J Webber, Paul D P Pharoah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2018
Development and External Validation of Prediction Models for 10-Year Survival of Invasive Breast Cancer. Comparison with PREDICT and CancerMathSolon Karapanagiotis, Paul D P Pharoah, Christopher H Jackson, et al.
Pageof 57

Showing results (41-50 of 566) with videos related to

Sort By:
Pageof 57
British Journal of Cancer|February 18, 2011
Patient and tumour characteristics, management, and age-specific survival in women with breast cancer in the East of EnglandA M G Ali, D Greenberg, G C Wishart, et al.
JAMA Oncology|July 7, 2018
Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table ModelNora Pashayan, Steve Morris, Fiona J Gilbert, et al.
Human Molecular Genetics|September 26, 2007
Cancer genetics of epigenetic genesAhmad Miremadi, Mikkel Z Oestergaard, Paul D P Pharoah, et al.
Plos Genetics|June 30, 2018
The importance of using public data to validate reported associationsGeorgia Chenevix-Trench, Jonathan Beesley, Paul D P Pharoah, et al.
Nature Reviews. Cancer|July 21, 2023
Polygenic scores in cancerXin Yang, Siddhartha Kar, Antonis C Antoniou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
An analysis of ovarian tumor diameter and survivalJ. F. Stratton, P. Pharoah, J. A. Tidy, et al.
Journal of Medical Ethics|April 4, 2003
Issues of consent and feedback in a genetic epidemiological study of women with breast cancerM P M Richards, M Ponder, P Pharoah, et al.
JAMA Network Open|March 11, 2021
Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate CancerThomas Callender, Mark Emberton, Stephen Morris, et al.
BMC Cancer|May 31, 2008
Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancerGrace M Callagy, Mark J Webber, Paul D P Pharoah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2018
Development and External Validation of Prediction Models for 10-Year Survival of Invasive Breast Cancer. Comparison with PREDICT and CancerMathSolon Karapanagiotis, Paul D P Pharoah, Christopher H Jackson, et al.
Pageof 57